SUSQUEHANNA INTERNATIONAL GROUP, LLP - COEPTIS THERAPEUTICS HLDGS I ownership

COEPTIS THERAPEUTICS HLDGS I's ticker is and the CUSIP is 19207A108. A total of 16 filers reported holding COEPTIS THERAPEUTICS HLDGS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of COEPTIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2023$12,697
-49.9%
10,946
-33.0%
0.00%
Q4 2022$25,32916,3410.00%
Other shareholders
COEPTIS THERAPEUTICS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,212,000$2,565,9200.04%
Sea Otter Advisors LLC 45,000$52,2000.03%
Ionic Capital Management LLC 45,000$52,2000.01%
Shaolin Capital Management LLC 45,000$520.00%
Creative Planning 645,103$748,3190.00%
OSAIC HOLDINGS, INC. 67$780.00%
WELLS FARGO & COMPANY/MN 108$1250.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 124,709$144,6940.00%
WOLVERINE ASSET MANAGEMENT LLC 222$2570.00%
View complete list of COEPTIS THERAPEUTICS HLDGS I shareholders